Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare Therapeutics's platform combines CRISPR‐enabled gene-editing target discovery technology with high‐resolution protein crystallography, computational biology, medicinal chemistry, and clinical informatics.
Market capitalization (7-Sept-2021)
Closing stock price (7-Sept-2021)
Repare Therapeutics has 761 Twitter Followers. The number of followers has increased 0.9% month over month and increased 10.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Repare Therapeutics founded?
Repare Therapeutics was founded in 2016.
Who are Repare Therapeutics key executives?
Repare Therapeutics's key executives are Lloyd M. Segal, Steve Forte and Maria Koehler.
How many employees does Repare Therapeutics have?
Repare Therapeutics has 102 employees.
Who are Repare Therapeutics competitors?
Competitors of Repare Therapeutics include SpringWorks Therapeutics, Agios Pharmaceuticals and Blueprint Medicines.
Where is Repare Therapeutics headquarters?
Repare Therapeutics headquarters is located at 7210 Rue Frederick Banting #100, Saint-Laurent, Montréal.
Where are Repare Therapeutics offices?
Repare Therapeutics has offices in Montréal and Cambridge.
How many offices does Repare Therapeutics have?
Repare Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies